Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

COLUMBIA PAIN MANAGEMENT, INC.

NPI: 1477670172 · HOOD RIVER, OR 97031 · Interventional Pain Medicine Physician · NPI assigned 03/26/2007

$1.08M
Total Medicaid Paid
27,839
Total Claims
22,763
Beneficiaries
15
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialRIGERT, TREY (PROVIDER)
NPI Enumeration Date03/26/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,895 $128K
2019 3,829 $163K
2020 5,020 $191K
2021 5,214 $178K
2022 4,059 $160K
2023 3,778 $170K
2024 3,044 $92K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11,354 9,338 $515K
99215 Prolong outpt/office vis 2,629 2,103 $165K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7,535 6,100 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2,331 2,059 $141K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2,161 1,546 $67K
90837 Psychotherapy, 53 minutes with patient 348 283 $21K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 126 114 $3K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 610 572 $2K
95886 12 12 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 77 65 $946.25
96138 84 73 $845.71
96132 29 27 $279.80
99072 247 230 $157.32
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 63 52 $119.71
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 233 189 $39.84